Latest filing published 13 Feb 2026 for Tyra Biosciences, Inc., €56k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Daniel Bensen on record concern Tyra Biosciences, Inc., in the capacity of chief executive. Over a trading history stretching from 17 September 2021 to 12 February 2026, the count stands at 82 filings.
No open-market purchase appears, only 55 sales worth €8.5M. Other entries cover 26 option exercises. So far in 2026, the count stands at no purchases and 4 sales.
On 13 February 2026 came the latest disclosure, an open-market sale for €165k in Tyra Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations